论文著作：
[1] A novel 5-Fluorouracil carbonate-loaded liposome: preparation, in vitro and in vivo evaluation as an antitumor agent, Molecular Pharmaceutics, 2022 (19):2061-2076, 2022
[2] Promoted antitumor therapy on pancreatic cancer by a novel recombinant human albumin-bound miriplatin nanoparticle, European Journal of Pharmaceutical Sciences, 167: e106000, 2021.
[3] Antisense microRNA185 loaded liposome for efficient inhibition of the hepatic endogenous microRNA185 level, European Journal of Pharmaceutical Sciences, 161: e105803, 2021.
[4]. Evaluation of antitumor efficacy of folate-poly(2-ethyl-2-oxazoline)-distearoyl phosphatidyl ethanolamine based liposome, Pharmaceutical Development and Technology, 26(1):110-118, 2021.
[5] Endocytosis and Organelle targeting of nanomedicines in cancer therapy. International journal of nanomedicine.15: 9447-9467, 2020.
发明专利：
获授权专利 19 件， 5 件代表性授权专利：
[1] miRNA185抑制剂的脂质体及其制法，ZL 202010993492.4, 2022-02-25 授权。
[2] 抗肿瘤化合物，ZL 202011145601.3, 2022-02-22 授权。
[3] 白蛋白纳米组合物及其制法，ZL 202010154790.4, 2021-09-14 授权。
[4] 脂质组合物及提高药物抗肿瘤活性的方法，ZL 201910369077.9, 2021-02-26 授权。
[5] 提高药物抗肿瘤活性的方法，ZL 201910369362.0, 2020-09-11 授权。
夏桂民
北京市
研究领域：
生物医药
研究方向：
纳米递送系统及药物缓控释制剂。
所在单位：
中国医学科学院北京协和医学院
